Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill nytimes.com/2026/02/07/hea… via @NYTimes

US FDA Flags Launch Ad For Novo Nordisk’s Wegovy Pill; Is Super Bowl Commercial Next? insights.citeline.com/pink-sheet/com…

#FDA #OPDP still raining letters: Sobi's VONJO fda.gov/media/191036/d…; Novo Nordisk's WEGOVY fda.gov/media/191020/d… argenx' s VYVGART HYTRULO fda.gov/media/191009/d… & fda.gov/media/191010/d…

Novo Nordisk’s Wegovy Pill Super Bowl Commercial May Draw US FDA Penalty Flag insights.citeline.com/pink-sheet/com…

Bayer sues J&J over ‘deeply flawed’ Erleada promotional claims fiercepharma.com/marketing/baye…

#FDA #OPDP letters Novo Nordisk' OZEMPIC re broadening the indication and implied superiority claims fda.gov/media/191387/d…

Novo lands another FDA untitled letter, this time for Apple-inspired Ozempic ad fiercepharma.com/marketing/novo…

The FDA is targeting telehealth marketing of GLP-1 drugs. Who’s prescribing them? statnews.com/2026/03/12/fda… via STAT

US FDA Snares Ozempic, Tremfya DTC Ads For Overstating Efficacy, GLP-1 Crackdown Continues insights.citeline.com/pink-sheet/com…

A Maryland legislator wants pharma and patient groups to disclose ties to disease awareness campaigns statnews.com/pharmalot/2026… via STAT

ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode fiercepharma.com/marketing/immu…

Health influencers talk social media and mental health statnews.com/2026/03/26/hea… via STAT

You Oughta Know: Companies Should Pay Attention When OPDP Drops a Warning Letter agg.com/news-insights/…

How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits fiercepharma.com/marketing/how-…

Over-the-top psychedelic promos could undermine the field’s drug development efforts statnews.com/2026/03/31/psy… via STAT

BMS, Novartis, Gilead, Iovance dinged over biologics promos in rare spate of CBER untitled letters fiercepharma.com/marketing/bms-…

FDA seeks legislative teeth to bite back against misleading DTC drug ads fiercepharma.com/marketing/fda-…

ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols fiercepharma.com/marketing/immu…

Does FDA Untitled Letter For Adcetris Facebook Ads Signal Start Of Social Media Crackdown? insights.citeline.com/pink-sheet/com…

Pfizer rebuked by FDA for misleading Adcetris ads on Facebook fiercepharma.com/marketing/pfiz…